Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)Release Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA HER2 Expression in Urothelial Carcinoma (UC)Release Date:Education Oncology All Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Benin, Congo, The Democratic Republic Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology USA Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate VaccinationRelease Date:Education Vaccines USA Community Oncology Support for Therapy Management in Multiple Myeloma (MM)Release Date:Education Oncology USA Management of Adults and Adolescents with Alopecia AreataRelease Date:Education Inflammation & Immunology USA Sickle Cell Disease Transition in CareRelease Date:Partner: National Alliance of Sickle Cell CentersQuality Improvement Rare Disease USA 2025 Rheumatology Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)Release Date:Education Inflammation & Immunology USA Invasive Mold Diseases (IMD) & Treatment OutcomesRelease Date:Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom Implementing Updated RSV Immunization Recommendations for Older AdultsRelease Date:Education Vaccines USA